Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Metvix PDT recommended for approval in Australia

Feb. 27, 2003

No Comments

MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies

Feb. 27, 2003

No Comments

Label for Botox widened in Europe

Feb. 27, 2003

No Comments

Promising results reported for Targretin in chronic severe hand dermatitis

Feb. 25, 2003

No Comments

Delay announced in European approval for Amevive

Feb. 21, 2003

No Comments

Pharmacodynamics and pharmacokinetics of infliximab in psoriatic patients

Feb. 18, 2003

No Comments

Serono's Raptiva marketing rights extended to Asia

Feb. 10, 2003

No Comments

Novel PLA2 inhibitors discovered by Nippon Soda scientists

Feb. 10, 2003

No Comments

Leo Pharma validates psoriasis target from Switch Biotech

Feb. 7, 2003

No Comments

Improvement of hyperandrogenic alopecia in women after 1-year treatment with flutamide

Feb. 5, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

Metvix PDT recommended for approval in Australia

MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies

Label for Botox widened in Europe

Promising results reported for Targretin in chronic severe hand dermatitis

Delay announced in European approval for Amevive

Pharmacodynamics and pharmacokinetics of infliximab in psoriatic patients

Serono's Raptiva marketing rights extended to Asia

Novel PLA2 inhibitors discovered by Nippon Soda scientists

Leo Pharma validates psoriasis target from Switch Biotech

Improvement of hyperandrogenic alopecia in women after 1-year treatment with flutamide

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Dermatologic RSS

Dermatologic
RSS